Late Phase
Clinical Trial Solutions
Invicro’s clinical capabilities span from early phase, first-in-human through late phase and post-approval studies. We focus on studies containing imaging and pathology-based endpoints requiring robust, independent assessments to ascertain drug efficacy.
Our imaging core lab and CAP/CLIA lab-based pathology services solutions support various therapeutic areas including oncology, immuno-oncology, neurology (CNS), cardiovascular, musculoskeletal and gastrointestinal. Our experience comes from years of successful execution of Phase II-IV studies across the development spectrum led by a leadership team with an average of 25 years of industry experience.
Modalities
As a leading imaging and pathology services provider, we acquire, store, analyze, and report data needed to help biopharmaceutical partners make decisions about their drug development programs. Invicro supports a broad range of modalities to evaluate key clinical endpoints in clinical studies including:
- CT
- MRI
- PET
- SPECT
- NM bone scan
- Echo
- X-ray
- Photography
- Ultrasound
- Core histology
- Multiplex Immunohistochemistry (IHC)
- Multiplex Immunofluorescence (IF)
- Quanticell™ High sensitivity Immunohistochemistry (IHC)
- RNAScope® ISH
- BaseScope™ ISH
- Additional Modalities Available
Therapeutic Areas
Thought Leadership Content
Case Studies
Rhesus Teeth Segmentation by Use of Multi-Atlas Library
Lipid Quantification Tool Development Using Multi-Echo MRI
Webinars
Segmentation of Lesions in Whole-Body PET/CT Using Deep Learning
Utilizing Imaging Agent Biomarkers for Improved Patient Management – Challenges and Successes
PSMA: Imaging Biomarker Development
The Changing Landscape of Response Assessment in Oncology
Molecular Imaging in Neurodegenerative Disorders: Developing a Translational Toolbox
Wherefore art Tau? Developing Methods for the Qualitative Interpretation of Tau PET
The IQ Analytics Platform: Amyloid-IQ, Tau-IQ and Dat-IQ
What Can we Learn from Primary Age-Related Tauopathy (PART)
Chemistry External Manufacturing and Network Management
Obtaining High Quality Imaging Data from Clinical Trials